Dr Reddys Laboratories has announced its US specialty business with the launch of Promius Pharma, a wholly-owned subsidiary of Dr Reddy Laboratories located in Bridgewater, NJ.
Promius Pharma, which will initially focus art the branded dermatology market, is based on a platform of strategic licensing initiatives and internal product development activities undertaken over the last several years. Promius Pharmas product portfolio currently comprises of three in-licensed and co-developed dermatological products that are scheduled to launch within calendar years 2008-09, and a pipeline of topical products being developed at the integrated product development facility in Hyderabad, India. Promius Pharmas current portfolio contains innovative topical products for the treatment of psoriasis, atopic dermatitis and seborrheic dermatitis.
The company made this announcement during the trading hours today, 18 September 2008.
No comments:
Post a Comment